Medscape26d
Empagliflozin Benefits Heart Failure Even With Low BP
Empagliflozin improved clinical outcomes in patients with acute heart failure (AHF), regardless of blood pressure (BP) levels, with particularly strong benefits observed in those with diastolic BP ...
pharmaphorum3y
FDA approves Jardiance (empagliflozin) for wider range of patients with heart failure
Jardiance is also authorised to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. According to the FDA, heart disease impacts more than ...
The Hindu17d
With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Earlier this week, German manufacturer Boehringer Ingelheim’s patent to manufacture Empagliflozin, a medication to treat type 2 diabetes mellitus, expired in India. Empagliflozin is sold under ...
moneycontrol.com22d
Cost of major diabetes drug set to drop significantly; here's why
The diabetes care landscape in India is set for a major transformation as domestic pharmaceutical companies reportedly prepare to launch low-cost generic versions of Empagliflozin. The move comes ...